Scorpion Therapeutics is a Biotech company based in Boston. It has raised $515M in total funding. Latest round: Series D. Backed by Atlas Venture, Lilly.
Scorpion Therapeutics is a Biotech company based in Boston. Scorpion Therapeutics has raised $515M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in May 2025. The round record for Scorpion Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Atlas Venture, Lilly. 2 distinct backers are named across the disclosed rounds.
Scorpion Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Boston below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026